Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox’s Partner Ocumension Therapeutics Initiates ZERVIATE Phase 3 Clinical Trial in China

December 30, 2020

View Press Release Corporate presentation Contact us
Previous